跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FOLOTYN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
FOLOTYN
Authorized
STANDARD
FOLOTYN
servier canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
3b1fcb95648bc804
Company
servier canada inc
Type
Standard
Approval Details
Approval Id
3b1fcb95648bc804
Drug Approval Canada Name
FOLOTYN
Product Name
FOLOTYN
Status
Marketed
Status Date
2019-01-15
Original Market Date
2019-01-15
Din
02481820
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01BA05 PRALATREXATE%
Atc Name
l 01 ba 05
Aig Number
0160770001
Company Name
servier canada inc
Company Address
270, 3224 Avenue Jean-Béraud, Laval, Quebec, Canada, H7T 2S4
Active Ingredients
PRALATREXATE
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
3b1fcb95648bc804
Type
Standard
Back to Health Canada Approvals